Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-22

Clinical Trial Update: Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing sacubitril/valsartan to ramipril in patients with renal dysfunction hospitalized for acute decompensated heart failure has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)
  • Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: National Heart Institute, Egypt | Conditions: Acute Decompensated Heart Failure (ADHF), Chronic Kidney Disease (CKD) | Phase 2, Phase 3 | Status: COMPLETED